鍦ㄦ涔嬪墠锛屻€婃境鏂伴鍝佹爣鍑嗘硶鍏搞€�2.9.5鍙锋爣鍑嗛檮浠�29-20宸叉壒鍑哃-璧栨皑閰搁唻閰搁叝鐢ㄤ簬鐗瑰尰椋熷搧锛圠-璧栨皑閰搁唻閰搁叝涓篖-姘ㄥ熀閰搁叝鐨勪竴绉嶏級銆傞闄╄瘎浼扮粨璁鸿涓猴紝L-姘ㄥ熀閰搁叝鐢ㄤ簬鐗瑰尰椋熷搧鏃犲仴搴烽闄┿€傛柊瑗垮叞鍒濈骇浜т笟閮ㄦ彁鍑烘湰娆¤姹傦紝鏃ㄥ湪淇濋殰浜轰綋鍋ュ悍锛屽苟娑堥櫎瀵硅锤鏄撶殑涓嶈壇褰卞搷銆�
閮ㄥ垎鍘熸枃鎶ラ亾濡備笅锛�
FSANZ is considering an urgent Proposal prepared to remove a negative effect on trade in food for special medical purposes and has prepared a draft food regulatory measure. Pursuant to section 96 of the Food Standards Australia New Zealand Act 1991 锛團SANZ Act锛夛紝 FSANZ now calls for submissions to assist its consideration of that draft food regulatory measure.
The Proposal has been declared an urgent Proposal for the purposes of Division 4 of Part 3 of the Food Standards Australia New Zealand Act 1991 锛圕th锛� 锛坱he FSANZ Act锛�.
Standard 2.9.5 and Schedule 29-20 of the Code currently permit L-lysine acetate as the only acetate form of single L-amino acids for use in FSMP.
鏈枃鐢遍鍝佷紮浼寸綉椋熷搧璧勮涓績缂栬緫锛屼緵缃戝弸鍙傝€冿紝娆㈣繋杞浇锛岃浆杞借娉ㄦ槑鍑哄锛佹湁浠讳綍鐤戦棶锛岃鑱旂郴news@www.sqrdapp.com銆�
鏈枃鐢遍鍝佷紮浼寸綉椋熷搧璧勮涓績缂栬緫锛屼緵缃戝弸鍙傝€冿紝娆㈣繋杞浇锛岃浆杞借娉ㄦ槑鍑哄锛佹湁浠讳綍鐤戦棶锛岃鑱旂郴news@www.sqrdapp.com銆�